9 April 2005 – LAWFUEL – The Law News Network – The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange Act”), of trading of the securities of Bio-Heal Laboratories, Inc. (“Bio-Heal”), of Carson City, Nevada at 9:30 a.m. EDT on April 8, 2005 and terminating at 11:59 p.m. EDT on April 21, 2005.
The Commission temporarily suspended trading in the securities of Bio-Heal because of questions raised regarding Bio-Heal’s issuance of approximately 12 million shares of common stock in purported reliance on Rule 504 of Regulation D of the Securities Act of 1933. Bio-Heal, a company that is delinquent in its periodic filing obligations under Section 13(a) of the Exchange Act, is quoted on the Pink Sheets under the ticker symbol BHLL.
The Commission cautions brokers, dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.
Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff of the Securities and Exchange Commission in Washington, D.C. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to Bio-Heal’s securities until such time as he has familiarized himself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider the need for prompt enforcement action.
If any broker, dealer or other person has any information which may relate to this matter, they should immediately communicate it to Christine Lynch, Branch Chief, Southeast Regional Office of the Securities and Exchange Commission. She can be reached at (305) 982-6312 or by e-mail at [email protected]